Interim C-reactive protein levels predict the prognosis of patients with metastatic colorectal cancer receiving immunotherapy: a retrospective cohort study
Background: Serum C-reactive protein (CRP) level is frequently considered a prognostic predictor of immunotherapy. However, the prognostic role of the interim serum CRP levels before the third course of immunotherapy (CRP-C3) in patients with metastatic colorectal cancer (mCRC) receiving immunothera...
Saved in:
| Main Authors: | Hai-Yan Fu, Yi-Yang Zhang, Jin-Shan Huang, Jin-Xin Hu, Kun-Hao Bai, Zhi-Qiang Wang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-07-01
|
| Series: | Therapeutic Advances in Medical Oncology |
| Online Access: | https://doi.org/10.1177/17588359251356581 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Gut markers for metastatic melanoma receiving immunotherapy
by: Guoping Ou, et al.
Published: (2025-07-01) -
A PET-CT radiomics model for immunotherapy response and prognosis prediction in patients with metastatic colorectal cancer
by: Wenbiao Chen, et al.
Published: (2025-05-01) -
Predicting prognosis and immunotherapy response of ferroptosis-related genes in colorectal cancer
by: Hongyun Wei, et al.
Published: (2025-06-01) -
Total cell-free DNA, carcinoembryonic antigen, and C-reactive protein for assessment of prognosis in patients with metastatic colorectal cancer
by: Karen-Lise Garm Spindler, et al.
Published: (2018-11-01) -
Postoperative complications are associated with worse survival after laparoscopic surgery for non-metastatic colorectal cancer – interim analysis of 3-year overall survival
by: Michał Nowakowski, et al.
Published: (2018-06-01)